GSK to raise stake in India unit in $ 939 m deal

Tuesday, 27 November 2012 00:00 - - {{hitsCtrl.values.hits}}

Reuters: GlaxoSmithKline Plc plans to buy up to an additional 31.8% stake in its Indian consumer products arm GlaxoSmithKline Consumer Healthcare Ltd. for 52.2 billion rupees, sending shares of the Indian unit to a record high.

GlaxoSmithKline plans to raise its stake in GSK Consumer Healthcare to 75% from 43.2%, paying 3,900 rupees per share through an open offer, it said in a statement. The price represents a premium of 28% to the stock’s Friday close.

The offer period is expected to begin in January 2013.

“This transaction represents a further step in GSK’s strategy to invest in the world’s fastest growing markets and, we believe, offers a liquidity opportunity at an attractive premium for existing shareholders,” said David Redfern, Chief Strategy Officer at GlaxoSmithKline.

Shares in GSK Consumer Healthcare were locked at 3,659.20 rupees, up 20%, their maximum daily trading limit, while the Mumbai market was up 0.23%, by 9:17 a.m.

Securities regulations in India require a minimum public shareholding of 25% for a company to maintain a public listing.

Discover Kapruka, the leading online shopping platform in Sri Lanka, where you can conveniently send Gifts and Flowers to your loved ones for any event including Valentine ’s Day. Explore a wide range of popular Shopping Categories on Kapruka, including Toys, Groceries, Electronics, Birthday Cakes, Fruits, Chocolates, Flower Bouquets, Clothing, Watches, Lingerie, Gift Sets and Jewellery. Also if you’re interested in selling with Kapruka, Partner Central by Kapruka is the best solution to start with. Moreover, through Kapruka Global Shop, you can also enjoy the convenience of purchasing products from renowned platforms like Amazon and eBay and have them delivered to Sri Lanka.